share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

辉瑞 | 4:持股变动声明-高管 Denton David M
美股sec公告 ·  06/03 18:36
Moomoo AI 已提取核心信息
Pfizer Inc.'s Chief Financial Officer & EVP, Denton David M, completed a sale of 12,107 shares of common stock on May 31, 2024. The transaction was carried out at a price of $28.66 per share, resulting in a total value of $346,986.62. Following the sale, Denton David M's direct holdings in Pfizer common stock amounted to 37,919 shares. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
Pfizer Inc.'s Chief Financial Officer & EVP, Denton David M, completed a sale of 12,107 shares of common stock on May 31, 2024. The transaction was carried out at a price of $28.66 per share, resulting in a total value of $346,986.62. Following the sale, Denton David M's direct holdings in Pfizer common stock amounted to 37,919 shares. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
辉瑞公司的致富金融暨执行副总裁Denton David M于2024年5月31日完成了12107股普通股的出售。交易价格为每股28.66美元,总价值为346,986.62美元。出售后,Denton David M在辉瑞普通股中的直接持股达到了37,919股。此交易是通过交易代码“F”执行的,目的是通过交付或扣留证券来支付行权价格或税务责任。
辉瑞公司的致富金融暨执行副总裁Denton David M于2024年5月31日完成了12107股普通股的出售。交易价格为每股28.66美元,总价值为346,986.62美元。出售后,Denton David M在辉瑞普通股中的直接持股达到了37,919股。此交易是通过交易代码“F”执行的,目的是通过交付或扣留证券来支付行权价格或税务责任。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息